DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [31] A Computational Study to Identify Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) from Eucalyptus Active Compounds
    Muhammad, Ibrahim Ahmad
    Muangchoo, Kanikar
    Muhammad, Auwal
    Ajingi, Ya'u Sabo
    Muhammad, Ibrahim Yahaya
    Umar, Ibrahim Dauda
    Muhammad, Abubakar Bakoji
    COMPUTATION, 2020, 8 (03)
  • [32] Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
    Zagorska, Agnieszka
    Czopek, Anna
    Fryc, Monika
    Jonczyk, Jakub
    BIOMOLECULES, 2024, 14 (07)
  • [33] In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors
    Ibrahim, Mahmoud A. A.
    Abdelrahman, Alaa H. M.
    Mohamed, Tarik A.
    Atia, Mohamed A. M.
    Al-Hammady, Montaser A. M.
    Abdeljawaad, Khlood A. A.
    Elkady, Eman M.
    Moustafa, Mahmoud F.
    Alrumaihi, Faris
    Allemailem, Khaled S.
    El-Seedi, Hesham R.
    Pare, Paul W.
    Efferth, Thomas
    Hegazy, Mohamed-Elamir F.
    MOLECULES, 2021, 26 (07):
  • [34] In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
    Harisna, Azza Hanif
    Nurdiansyah, Rizky
    Syaifie, Putri Hawa
    Nugroho, Dwi Wahyu
    Saputro, Kurniawan Eko
    Firdayani
    Prakoso, Chandra Dwi
    Rochman, Nurul Taufiqu
    Maulana, Nurwenda Novan
    Noviyanto, Alfian
    Mardliyati, Etik
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 26
  • [35] In silico screening of potential SARS-COV-2 MAIN protease inhibitors from thymus Schimperi
    Mengist, H. M.
    Zunera, K.
    Fentahun, A.
    CLINICA CHIMICA ACTA, 2024, 558 : 28 - 28
  • [36] Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach
    Lima, Adrianne M.
    de Souza, Adson A.
    Amaral, Jackson L.
    Freire, Valder N.
    Souza, Pedro F.
    de Oliveira, Hermogenes D.
    FUTURE VIROLOGY, 2023, 18 (07) : 439 - 454
  • [37] Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study
    Morteza Sadeghi
    Mehran Miroliaei
    In Silico Pharmacology, 10 (1)
  • [38] Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor
    Agrawal, Pawan K.
    Agrawal, Chandan
    Blunden, Gerald
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (04)
  • [39] Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
    Jan, Zainab
    Geethakumari, Anupriya M.
    Biswas, Kabir H.
    Jithesh, Puthen Veettil
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2023, 21 : 3665 - 3671
  • [40] Amphibian-Derived Peptides as Natural Inhibitors of SARS-CoV-2 Main Protease (Mpro): A Combined In Vitro and In Silico Approach
    Spinelli, Roque
    Sanchis, Ivan
    Rietmann, Alvaro
    Humpola, Maria Veronica
    Siano, Alvaro
    CHEMISTRY & BIODIVERSITY, 2025,